{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-047090","form_type":"8-K","ticker":"IDXG","cik":"0001054102","company_name":"INTERPACE BIOSCIENCES, INC.","filed_at":"2026-10-15T10:10:45+00:00","discovered_at":"2026-10-15T10:15:00.351492+00:00","generated_at":"2026-10-15T10:15:09.125462+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Interpace Biosciences prelim Q3 2026 revenue $10.1M-$10.4M, up ~15-18% YoY","bullets":["Preliminary unaudited Q3 2026 revenue expected to range $10.1 million to $10.4 million.","Expected ~11%-14% quarter-over-quarter growth from $9.1 million in Q2 2026 and ~15%-18% year-over-year growth from $8.8 million in Q3 2025.","Results are preliminary and subject to quarter-end closing procedures and review by the company's independent registered public accounting firm.","Press release furnished as Exhibit 99.1; full Q3 2026 financial results expected to be reported at a later date.","Release references a free writing prospectus related to an offering with a registration statement filed with the SEC."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-047090","json":"https://secwatch.observer/filing/0001493152-26-047090.json","markdown":"https://secwatch.observer/filing/0001493152-26-047090.md","text":"https://secwatch.observer/filing/0001493152-26-047090.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1054102/000149315226047090/0001493152-26-047090-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1054102/000149315226047090/form8-k.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-15T10:15:09.125462+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}